Sun Pharmaceutical Industries
-
Taro in merger agreement with Sun Pharma
Post completion of the merger, the combined entity will firmly move forward, leveraging its global strengths and capabilities to better…
Read More » -
Sun Pharma, Zydus sign licensing agreement for co-marketing of anaemia-associated CKD drug Desidustat
The drug will be marketed by Sun Pharma under the brand name RYTSTAT Sun Pharmaceutical Industries and Zydus Lifesciences (including…
Read More » -
Sun Pharma, Pharmazz in licensing agreement for Tyvalzi (Sovateltide)
Sovateltide is a first-of-its-kind drug to treat acute cerebral ischemic stroke that can be administered up to 24 hours after…
Read More » -
Sun Pharma, Philogen in agreement to commercialise NIDLEGY in Europe, Australia, New Zealand
Nidlegy, currently in Phase III clinical trials, is a new anti-cancer biopharmaceutical which is being developed by Philogen for the…
Read More » -
Sun Pharma launches novel therapy for dry eye disease CEQUA(R) in India
CEQUA is the first dry eye treatment available in India that is delivered with nanomicellar (NCELL) technology Sun Pharmaceutical Industries…
Read More » -
Sun Pharma to acquire stakes in Agatsa Software, Remidio Innovative Solutions
Agatsa Software is an early-stage digital diagnostic devices company and Remidio Innovative Solutions provides products enabling the early detection of…
Read More » -
Sun Pharma launches SEZABY in US to treat neonatal seizures
SEZABY is a benzyl alcohol-free and propylene glycol-free formulation of phenobarbital sodium powder for injection Sun Pharmaceutical Industries announced the…
Read More » -
Sun Pharma launches breast cancer drug Palbociclib
Palbociclib has a unique mechanism of action which helps in delaying disease progression when co-administered with hormonal therapies1 Sun Pharmaceutical…
Read More » -
Sun Pharma, SPARC in pact for commercialisation of phenobarbital for injection in US
Sun Pharma will pay SPARC an upfront payment of $10 million A wholly-owned subsidiary of Sun Pharmaceutical Industries announced the…
Read More » -
Sun Pharma in license and supply agreement with Cosmo Pharma
Announce territory expansion for WINLEVI to include Japan, Australia, New Zealand, Brazil, Mexico and Russia Sun Pharmaceutical Industries and Cassiopea,…
Read More »
